Cargando…
HSP90, as a functional target antigen of a mAb 11C9, promotes stemness and tumor progression in hepatocellular carcinoma
BACKGROUND: Identification of promising targeted antigens that exhibited cancer-specific expression is a crucial step in the development of novel antibody-targeted therapies. We here aimed to investigate the anti-tumor activity of a novel monoclonal antibody (mAb) 11C9 and identify the antibody trac...
Autores principales: | Liu, Hui-Qi, Sun, Li-Xin, Yu, Long, Liu, Jun, Sun, Li-Chao, Yang, Zhi-Hua, Shu, Xiong, Ran, Yu-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523703/ https://www.ncbi.nlm.nih.gov/pubmed/37759328 http://dx.doi.org/10.1186/s13287-023-03453-x |
Ejemplares similares
-
SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023) -
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
por: Sun, Xun, et al.
Publicado: (2022) -
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015) -
Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015) -
USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2019)